Veranex Blog

EU Regulatory

1 min read

Critical Updates for Medical Device Manufacturers and Healthcare Institutions: Switzerland Aligns with EU IVDR Transitions

Switzerland has officially implemented its adapted Ordinance on In Vitro Diagnostic Medical Devices (ODiV), effective January 1, 2025. This strategic...

Read More

4 min read

Optimizing PLM-OEM Collaborations: Key Strategies for a Smooth IVDR Transition

Under Directive 98/69/EC (IVDD), it was common practice for in vitro diagnostic medical devices to be placed on the European market under contractual...

Read More

3 min read

Amending Regulation for MDR / IVDR: Key Takeaways for the Diagnostics Industry

The EU Parliament adopted the regulation amending EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to protect patients by ensuring the availability of...

Read More

4 min read

2024 IVDR Sprint: 6 Reasons Why You Should Start a Performance Evaluation Early

In accordance with Article 5(3) of Regulation (EU) 2017/746 (IVDR), a performance evaluation must be drawn up for every IVD placed on the European...

Read More

5 min read

Artificial Intelligence (AI), General Data Protection Regulation (GDPR) and Cybersecurity: 10 Misconceptions About Medical Device Software

Medical Device Software (MDSW) is a growing, fast-evolving industry. However, manufacturers must often face a regulatory framework which does not...

Read More

2 min read

Prioritizing Patient Safety and Fostering Innovation with the MHRAs New Roadmap for Medical Devices

On January 9, the United Kingdom (UK)’s Medicines and Healthcare Products Regulatory Agency (MHRA) released a regulatory framework – Roadmap towards...

Read More

2 min read

New Proposal for Extended Transition Periods for IVDs: Can Manufacturers Slow Down Transition Efforts? 

On 23 January 2024, the EU Commission published a new proposal for amending the regulations EU 2017/745 (MDR) and EU 2017/746 (IVDR) aiming to...

Read More

5 min read

Medical Device Vigilance: Important Considerations to Comply With the EU MDR

Vigilance reporting and postmarket surveillance of medical devices are among the many requirements documented in the EU MDR (2017/745) to ensure the...

Read More

1 min read

Possibility for Examination to be Included in the SHI Fee Scale Brings More Certainty for Reimbursement for New Diagnostics in Germany

Manufacturers can now have more certainty about the process of inclusion of a new laboratory, new human-genetic, or new tumor-genetic diagnostics in...

Read More